Close

Dr Laura Skrip

Assistant Professor

United Kingdom

I collaborate with social scientists, clinicians, basic science researchers, and communities to address contextually relevant questions about infectious disease spread, including through the use of mathematical models to quantify the potential impact of behaviour-focused tools and approaches on interrupting disease transmission. 

 

I have extensive experience working with national programs, including malaria control, immunization, and nutrition programs, as part of efforts to strengthen local capacity for evidence generation and utilization in post-Ebola Liberia. I have also studied barriers to building and sustaining capacity for advanced analysis to inform development of locally owned academic programs in West Africa.

Affiliations

Department of Infectious Disease Epidemiology and Dynamics
Faculty of Epidemiology and Population Health

Centres

Centre for Mathematical Modelling of Infectious Diseases

Teaching

I am passionate about teaching to strengthen skills for statistics and modelling as well as skills for the utilisation of modelling evidence. Within LSHTM, I am a co-module organiser for the Statistics for Epidemiology (EPM102) course in the Distance Learning Epi programme. I also remain actively involved in teaching and curriculum development at the University of Liberia School of Public Health and a Liberia-based NGO which offer opportunities to strengthen analytics skills among public health professionals in West Africa. Prospective sudents with interest in a One Health approach to modelling and data collection for emerging infectious diseases are welcome to be in touch.

Research

·       Modelling the role of socio-demographic and behavioral factors in spillover risk for emerging zoonoses

·       Designing methods to integrate cross-disciplinary data sources for modelling the context in which infectious diseases emerge and spread

·       Modeling the dynamic interplay of malnutrition and vaccine-preventable diseases

·       Studying the learning processes behind generation and use of disease modeling evidence

Research Area
Social epidemiology
Mathematical modelling
Vaccines
Capacity development
Behaviour change
Serology, vaccines
Disease and Health Conditions
Lassa fever
Ebola virus
COVID-19
Vector borne diseases
Emerging infectious diseases
Country
Liberia
Japan
Ethiopia
Sudan
Sierra Leone
Cameroon
Chad
Niger
Region
Sub-Saharan Africa (developing only)
East Asia & Pacific (all income levels)

Selected Publications

Identification of Contacts With High Rates of Missed and Asymptomatic Infection Following an Outbreak of Ebola Virus Disease: A Seroepidemiological Study in Likati Health Zone, Democratic Republic of the Congo.
Tshiani Mbaya, O; Ariyoshi, K; SKRIP, L; Kahusu, CM; Suangi, A; Mubiala, A; Tshomba, A; Yoshinao, K; Mumbere, G; Muyembe, J-J; Mulangu, S;
2026
Open forum infectious diseases
Changes in Incidence Associated With an Influenza Alert System Using Antiviral Dispensing Data From Goto City in Remote Islands of Japan: An Analytical Observational Study.
Miyata, J; SKRIP, L; Yamanashi, H; Koyamatsu, J; Shimoshikiryo, I; Nonaka, F; Sugahara, M; Sugahara, M; Ideguchi, N; Maeda, T;
2026
Journal of epidemiology
Enhancing data collection on socio-behavioral exposure pathways for emerging tickborne disease through engagement with surviving cases and their household members.
Hattori, C; Kurihara, J; Shimada, S; Yamaguchi, N; Kobayashi, C; Aono, H; Takamatsu, Y; Tanaka, T; Yamanashi, H; EDMUNDS, WJ; Ariyoshi, K; Hidano, A; Vessiere, A; SKRIP, L;
2026
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Vaccine value profile for severe fever with thrombocytopenia syndrome (SFTS).
SKRIP, L; Hidano, A; Poovorawan, Y; Khongwichit, S; Kato, H; Kapell, S; Abe, M; Jung, S-M; Jit, M; Kim, K-H; Yi, J; Miyazaki, T; Kawaguchi, T; Okabayashi, T; Chae, J-S; Ariyoshi, K; EDMUNDS, WJ; Morita, K;
2026
Vaccine
Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022-2023.
Koko, VS; SKRIP, L; Kumeh, O; Washington, T; Diallo, MO; Kafuko, J; Inyang, U; Ponce de León, GF; Zhou, Z; Laird, VR; Zawolo, J; Getahun, B; Harmon-Gray, W-M; Plucinski, M; Schultz, JS;
2025
Malaria journal
Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response.
KIM, S; KANG, H; SKRIP, L; Sahastrabuddhe, S; Islam, A; Jung, S-M; Vesga, JF; Endo, A; EDMUNDS, WJ; ABBAS, K;
2025
Expert review of vaccines
Research utilization competency development in the health workforce pipeline: Design and formative evaluation of learning objectives for health professions students.
Yini Karway, OW; Wleh, J; Kpatakolee, Y; Sieka, J; Candy, N; Talbert-Slagle, K; Dahn, BT; Harmon-Gray, W-M; SKRIP, LA;
2024
Health research policy and systems
Malaria treatment for prevention: a modelling study of the impact of routine case management on malaria prevalence and burden.
Camponovo, F; Jeandron, A; SKRIP, LA; Golumbeanu, M; Champagne, C; Symons, TL; Connell, M; Gething, PW; Visser, T; Menach, AL; Cohen, JM; Pothin, E;
2024
BMC infectious diseases
See more information